PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 10mL multi-dose injection vial Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

panvax h1n1 vaccine, h1n1 pandemic influenza vaccine (split-virion, inactivated) 10ml multi-dose injection vial

seqirus pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate; monobasic sodium phosphate; potassium chloride; monobasic potassium phosphate; calcium chloride dihydrate; thiomersal - for active immunisation to prevent influenza disease caused by the influenza a (h1n1) virus, in persons from 6 months of age.

Quadrivalent influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

quadrivalent influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes

split virion, inactivated) suspension for injection 0.5ml pre-filled syringes (sanofi - influenza virus split virion - suspension for injection

Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) Európai Unió - angol - EMA (European Medicines Agency)

adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human, immunization, disease outbreaks - vaccines, - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.,

Zoonotic Influenza Vaccine Seqirus Európai Unió - angol - EMA (European Medicines Agency)

zoonotic influenza vaccine seqirus

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - vaccines - active immunisation against h5 subtype of influenza a virus

INACTIVATED INFLUENZA VACCINE 15/15/15mc %v/v Suspension for Injection Írország - angol - HPRA (Health Products Regulatory Authority)

inactivated influenza vaccine 15/15/15mc %v/v suspension for injection

sanofi pasteur msd ltd - a/california/7/2009 (h1n1)pdm09 - derived strain used nymc x-179a, a/hong kong/4801/2014 (h3n2) - like strain (a/hong kong/4801/2014, nymc x-263b), b/brisbane/60/2008 - like strain (b/brisbane/60/2008) - suspension for injection - 15/15/15mc %v/v - influenza vaccines

Agrippal Suspension for injection in pre-filled syringe, Influenza Vaccine Surface Antigen, Inactivated(2017/2018 season) Írország - angol - HPRA (Health Products Regulatory Authority)

agrippal suspension for injection in pre-filled syringe, influenza vaccine surface antigen, inactivated(2017/2018 season)

seqirus s.r.l. - a/guangdong-maonan/swl 1536/2019 (h1n1)pdm09-like strain (a/guangdong-maonan/swl 1536/2019, cnic-1909); a/hong kong/2671/2019 (h3n2)-like strain (a/hong kong/2671/2019, ivr-208); b/washington/02/2019-like strain (b/washington/02/2019, wild type) - suspension for injection in pre-filled syringe - . - influenza vaccines; influenza, inactivated, split virus or surface antigen - influenza vaccine - prophylaxis of influenza, especially in those who run an increased risk of associated complications

Fluad, Suspension for injection in pre-filled syringeInfluenza Vaccine, Surface Antigen, Inactivated, Adjuvanted with MF59C.1(20 Írország - angol - HPRA (Health Products Regulatory Authority)

fluad, suspension for injection in pre-filled syringeinfluenza vaccine, surface antigen, inactivated, adjuvanted with mf59c.1(20

seqirus s.r.l. - a/michigan/45/2015 (h1n1) pdm09 - like strain (a/singapore/gp1908/2015, ivr-180a); a/singapore/imfimh-16-0019/2016 (h3n2)-like strain (a/singapore/infimh-16-0019/2016,nib-104); b/colorado/06/2017-like strain (b/victoria/2/87 lineage)(b/maryland/15/2016,nymc bx-69a) - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - influenza vaccines; influenza, inactivated, split virus or surface antigen - influenza vaccine - active immunisation against influenza in the elderly (65 years of age and over. refer to spc for detailed information.

Vaxigrip suspension for injection in prefilled syringe.Influenza vaccine (split virion, inactivated) Málta - angol - Medicines Authority

vaxigrip suspension for injection in prefilled syringe.influenza vaccine (split virion, inactivated)

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - influenza vaccine, split virion, inactivated - suspension for injection - influenza vaccine (split virion, inactivated) 15 µg - vaccines

Foclivia Európai Unió - angol - EMA (European Medicines Agency)

foclivia

seqirus s.r.l.  - influenza virus surface antigens, inactivated: a/viet nam/1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - influenza vaccines - prophylaxis of influenza in an officially declared pandemic situation.pandemic influenza vaccine should be used in accordance with official guidance.

Vepacel Európai Unió - angol - EMA (European Medicines Agency)

vepacel

ology bioservices ireland ltd - influenza virus (whole virion, inactivated), containing antigen of: a/vietnam/1203/2004 (h5n1) - influenza, human; immunization; disease outbreaks - influenza vaccines - active immunisation against h5n1 subtype of influenza a virus. this indication is based on immunogenicity data from subjects from the age of 6 months onwards following administration of two doses of vaccine prepared with h5n1 subtype strains. vepacel should be used in accordance with official guidance.,